Pentafluranol

Pentafluranol (INN, BAN; developmental code BX-430) is a synthetic, nonsteroidal estrogen of the stilbestrol group related to diethylstilbestrol that was developed for the treatment of benign prostatic hyperplasia never marketed.^[1][2] It was described in the medical literature in 1974.^[1]

Pentafluranol

Clinical data
ATC code	None
Identifiers
IUPAC name 2-Fluoro-4-[5,5,5-trifluoro-3-(3-fluoro-4-hydroxyphenyl)pentan-2-yl]phenol
CAS Number	65634-39-1
PubChem CID	3047826
ChemSpider	16737041
UNII	95RFZ48151
ChEMBL	ChEMBL2105409
CompTox Dashboard (EPA)	DTXSID001024356
Chemical and physical data
Formula	C17H15F5O2
Molar mass	346.297 g·mol−1
3D model (JSmol)	Interactive image
SMILES CC(C1=CC(=C(C=C1)O)F)C(CC(F)(F)F)C2=CC(=C(C=C2)O)F
InChI InChI=1S/C17H15F5O2/c1-9(10-2-4-15(23)13(18)6-10)12(8-17(20,21)22)11-3-5-16(24)14(19)7-11/h2-7,9,12,23-24H,8H2,1H3 Key:PRRSFMGODMUPJN-UHFFFAOYSA-N

See also

• Acefluranol
• Bifluranol
• Terfluranol